Monopar Therapeutics Inc. Other Non-Current Assets
Monopar Therapeutics Inc. (MNPR) had Other Non-Current Assets of $0 as of 2021-12-31, per its 10-K filed 2022-03-24.
Discontinued › Balance Sheet › Assets
us-gaap:OtherAssetsNoncurrent · last filed 2022-03-24
- 2021-12-31: Other Assets, Noncurrent $0.00.
- 2021-09-30: Other Assets, Noncurrent $68.86K.
- 2021-06-30: Other Assets, Noncurrent $68.86K.
- 2021-03-31: Other Assets, Noncurrent $68.86K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-24 |
| 2021-09-30 | $68.86K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $68.86K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $68.86K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $68.86K 10-K · filed 2022-03-24 |
| 2020-09-30 | $68.86K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $73.05K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $122.38K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $122.38K 10-K · filed 2021-03-25 |
| 2018-12-31 | $65.73K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |